Change of Chief Executive Officer
February 06, 2018 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), advises that the Board and Mr Eutillio Buccilli have today agreed...
Appointment of Chairman
February 05, 2018 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), is pleased to announce that the Board of Directors has appointed Dr...
Results from 31 January 2018 General Meeting
January 31, 2018 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) --
Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”) advises that a General Meeting of shareholders that had been...
Resignation of Directors
January 30, 2018 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), advises that Dr Malcolm R. Brandon and Mr Grahame Leonard, AM have resigned...
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
January 29, 2018 05:30 ET
|
Genetic Technologies Limited
HIGHLIGHTS Completed a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month Ohio State University: patient recruitment for the collaborative clinical...
Genetic Technologies Regains Nasdaq Listing Compliance
January 09, 2018 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), is pleased to advise that the Company received a notification letter (the...
Genetic Technologies Provides Update on Strategic Review Initiative
December 12, 2017 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company focused on cancer risk assessment, and...
Notice Received Under Section 249D of the Corporations Act
December 01, 2017 05:00 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), advises that on 29 November it received a notice under Section 249D of the...
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017
October 30, 2017 05:00 ET
|
Genetic Technologies Limited
HIGHLIGHTS Launched a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month BREVAGenplus commercial program to transition to an ecommerce based...
Genetic Technologies Transitions to Online Commercial Platform for BREVAGenplus®
September 21, 2017 05:30 ET
|
Genetic Technologies Limited
MELBOURNE, Australia, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company specialising in cancer genomics, and...